Abstract:BACKGROUND:Neuromyelitis optica (NMO) shows various brain magnetic resonance imaging (MRI) abnormalities with recurrent central nervous system (CNS) attacks, although predominantly affecting the spinal cord and optic nerve. However, NMO with extensive involvement of the brain has infrequently been studied. We investigated the clinical, radiographic features and immunomodulating changes of NMO patients with extensive brain lesions (EBLs) in China.METHODS:NMO patients (including 16 NMO patients with EBLs and 53 NMO patients without EBLs) hospitalized during January 2006 and February 2010 were recruited and analyzed retrospectively. Data of clinical characteristics, magnetic resonance imaging (MRI) features, laboratory abnormalities, treatment details and outcomes were analyzed. All the patients received the follow-up visits for two years.RESULTS:EBLs in NMO were classified into four categories according to their respective MRI characteristics: 1) Tumefactive-like lesions (n=4, 25%); 2) Acute disseminated encephalomyelitis (ADEM)-like lesions (n=6, 37.5%); 3) Multiple sclerosis (MS)-like lesions (n=5, 31.25%); 4) Posterior reversible encephalopathy syndrome (PRES)-like lesions (n=1, 6.25%). NMO patients with EBLs had higher rates of encephalopathy symptoms (37.5% vs. 5.6%, p = 0.004), homonymous hemianopia (18.8% vs. 0%, p = 0.011) and AQP4 seropositivity (100% vs. 69.8%, p = 0.008) than NMO patients without EBLs (NEBLs). Immunomodulating changes (including the levels of C3, C4, ESR and CRP) were significantly higher in patients with EBLs than those without EBLs. The relapse times in EBLs during the follow-up period were more frequent than those happened in NEBLs (1.88 ± 0.30 vs. 1.23 ± 0.14, p = 0.04). The EDSS scores in EBLs patients were also much higher than those in NEBLs throughout all the whole visits of follow-up.CONCLUSIONS:The presence of EBLs in NMO may indicate a higher diseases activity and portend a worse prognosis. CRP is a useful marker in monitoring diseases activity. Systemic inflammation may be crucial to the formation of EBLs in NMO.

Magnetic Resonance Image in Monitor and Diagnosis of Patients with Neuromyelitis Optica

The clinical and magnetic resonance imaging studies of brain damages in neuromyelitis optica

Brain Magnetic Resonance Imaging Abnormalities of Neuromyelitis Optica

Magnetic resonance imaging appearance of neuromyelitis optica in spinal cord

MRI in Neuromyelitis Optica

MRI Abnormalities and Related Risk Factors of the Brain in Patients with Neuromyelitis Optica

Comparative Analysis of the Clinical Symptoms and Magnetic Resonance Imaging Findings of the Spinal Cord in Patients with Neuromyelitis Optica and Multiple Sclerosis

Magnetic resonance imaging markers for multiple sclerosis and neuromyelitis optica spectrum disorders

The Clinical Value Study of NMO-IgG and MRI in Neuromyelitis Optica with Tumefactive Demyelinating

Relationship Between Neuromyelitis Optica-Igg Status and Spinal Cord Magnetic Resonance Imaging in Patients with Neuromyelitis Optica.

Clinical and Ocular Manifestation of Neuromyelitis Optica and Multiple Sclerosis

Clinical, Radiographic Characteristics and Immunomodulating Changes in Neuromyelitis Optica with Extensive Brain Lesions

Brain MRI characteristics in neuromyelitis optica spectrum disorders: A large multi-center retrospective study in China

Characteristic Linear Lesions and Longitudinally Extensive Spinal Cord Lesions in Chinese Patients with Neuromyelitis Optica

Multimodal Characterization of Gray Matter Alterations in Neuromyelitis Optica.

Neuromyelitis optica IgG and related clinical features of patients with neuromyelitis optica

Comparative Clinical Characteristics of Neuromyelitis Optica Spectrum Disorders with and Without Medulla Oblongata Lesions

Comparison on the Clinic Features and Neuromyelitis Optica-Igg Positive Rate of Neuromyelitis Optica and Multiple Sclerosis

Clinical and radiological characteristics of neuromyelitis optica with extensive brain lesions(16 cases)

Evaluation of brain and spinal cord lesion distribution criteria at disease onset in distinguishing NMOSD from MS and MOG antibody-associated disorder

Differential patterns of spinal cord and brain atrophy in NMO and MS.